Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.60 |
| ▸ | DNM1 | Q05193 | 9/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.48 |
| ▸ | RAD52 | P43351 | 2/20 | 0.48 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.45 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.45 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL61439 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL9691972 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL10933953 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL10932296 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL61125 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL6236479 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL10937742 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL60618 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL10975956 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL16604562 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 540 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11899020-B2 | Shotgun proteomic antigen identification | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-02-13 | — | — | US | claimed |
| CN-112444478-B | Sample cell for blood cell imaging counting and preparation method and application thereof | 华中师范大学 | 2023-10-17 | — | — | CN | claimed |
| US-11313863-B2 | Measurement of glycoprotein | ARKRAY, INC. (JP) | 2022-04-26 | — | — | US | claimed |
| EP-3903797-A1 | SOLUBILIZATION OF ANTIGEN COMPONENTS FOR REMOVAL FROM TISSUES | The Regents of The University of California (US) | 2021-11-03 | — | — | EP | claimed |
| EP-2919795-B1 | SOLUBILIZATION OF ANTIGEN COMPONENTS FOR REMOVAL FROM TISSUES | UNIV CALIFORNIA (US) | 2021-06-30 | — | — | EP | claimed |
| EP-2970639-B1 | FLEXIBLE NANOCRYSTALLINE CELLULOSE (NCC) FILMS WITH TUNABLE OPTICAL AND MECHANICAL PROPERTIES | CELLUFORCE INC (CA) | 2021-02-17 | — | — | EP | claimed |
| US-20200246449-A1 | INTRAVENOUS IMMUNOGLOBULIN COMPOSITIONS SPECIFIC FOR RESPIRATORY SYNCYTIAL VIRUS AND METHODS OF MAKING AND USING THE SAME | NANOBIO CORPORATION (US) | 2020-08-06 | — | — | US | claimed |
| US-10709813-B2 | Solubilization of antigen components for removal from tissues | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-07-14 | — | — | US | claimed |
| WO-2018204669-A1 | INTRAVENOUS IMMUNOGLOBULIN COMPOSITIONS SPECIFIC FOR RESPIRATORY SYNCYTIAL VIRUS AND METHODS OF MAKING AND USING THE SAME | NANOBIO CORPORATION (US) | 2018-11-08 | — | — | WO | claimed |
| US-20180161479-A1 | SOLUBILIZATION OF ANTIGEN COMPONENTS FOR REMOVAL FROM TISSUES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-06-14 | — | — | US | claimed |
| US-20060046261-A1 | Compositions and methods employing zwitterionic detergent combinations | SIGMA-ALDRICH CO. | 2006-03-02 | — | — | US | claimed |
| EP-1608392-A2 | PAPANICOLAU STAINING PROCESS | Cytyc Corporation (US) | 2005-12-28 | — | — | EP | claimed |
| WO-2005111608-A2 | TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY TEST REAGENTS AND METHODS USING THEM | IDEXX LABORATORIES, INC. (US) | 2005-11-24 | — | — | WO | claimed |
| US-20050239139-A1 | Transmissible spongiform encephalopathy test reagents and methods | IDEXX LABORATORIES, INC. (US) | 2005-10-27 | — | — | US | claimed |
| EP-0756633-B1 | METHOD AND KITS FOR PROCESSING MYCOBACTERIA AND MYCOLIC ACID CONTAINING BACTERIA | INTEGRATED RES TECHNOLOGY LLC (US) | 2005-06-08 | — | — | EP | claimed |
| WO-2004086945-A2 | PAPANICOLAU STAINING PROCESS | CYTYC CORPORATION (US) | 2004-10-14 | — | — | WO | claimed |
| US-20040191854-A1 | Papanicolau staining process | CYTYC CORPORATION | 2004-09-30 | — | — | US | claimed |
| EP-0878716-B1 | Measurement of LDL-cholesterol | WAKO PURE CHEM IND LTD (JP) | 2003-06-04 | — | — | EP | claimed |
| EP-0878716-A1 | Measurement of LDL-cholesterol | WAKO PURE CHEMICAL INDUSTRIES LTD (JP) | 1998-11-18 | — | — | EP | claimed |
| US-5814472-A | REACTING LIVING SAMPLE WITH CHOLESTEROL OXIDASE OR CHOLESTEROL DEHYDROGENASE IN PRESENCE OF AMPHOTERIC SURFACTANT AND CYCLODEXTRIN | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 1998-09-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11313863-B2 | Measurement of glycoprotein | HBG1, HBG2, HBB | HTT 1488/4885DNM1 4736/4885KMT2A 3253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.